This compound is a steroidal pharmaceutical intermediate used in the manufacture of neuromuscular blocking agents. It is characterized as a salt-like, multi-fragment structure with multiple stereocenters, containing alcohol, amine, and ether functional groups.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 119302-20-4
2beta-(4-Morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstane-3alpha,17beta-diol 17-acetate
Pharmaceutical intermediate for neuromuscular blocker
Sulfo-SNPB
Pharmaceutical intermediate
Sulfo-SPDB
Pharmaceutical intermediate for antibody-drug conjugate
4-Fluorobenzonitrile
Pharmaceutical intermediate for DPP-4 inhibitors
Cycloheptane-1,3-dione
Pharmaceutical intermediate for rosuvastatin synthesis
(2S,3S,5S,8R,9R,10S,13S,14R,16S,17R)-10,13-dimethyl-2-morpholin-4-yl-16-pyrrolidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol;(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-dimethyl-2-morpholin-4-yl-16-pyrrolidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
AQOKTKOEOSDJRC-NJYHMWOTSA-N
C[C@]12CC[C@@H]3[C@H]([C@H]1C[C@@H]([C@@H]2O)N4CCCC4)CC[C@@H]5[C@@]3(C[C@@H]([C@H](C5)O)N6CCOCC6)C.C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@@H]([C@@H]2O)N4CCCC4)CC[C@@H]5[C@@]3(C[C@@H]([C@H](C5)O)N6CCOCC6)C